pre-IPO PHARMA

COMPANY OVERVIEW

eXIthera Pharmaceuticals is an early stage biotech company focused on discovering and developing Factor XIa inhibitors for the prevention of thrombosis.


LOCATION

  • Westborough, MA, USA

  • THERAPEUTIC AREAS

  • Cardiovascular Disease

  • WEBSITE

    https://www.exithera.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS

    schooner-capitall


    PRESS RELEASES


    Mar 3, 2021

    eXIthera Pharmaceuticals Announces FDA Acceptance of IND Application for Phase 2 Trial of EP-7041 for Thrombosis Prevention in COVID-19 Patients


    For More Press Releases


    Google Analytics Alternative